The Differential and Dynamic Progression of Hepatic Inflammation and Immune Responses During Liver Fibrosis Induced by Schistosoma japonicum or Carbon Tetrachloride in Mice

Liver fibrosis can result from various causes and could progress to cirrhosis and cancer; however, there are no effective treatments due to that its molecular mechanism is unclear. liver fibrosis model made by Schistosoma japonicum (S. japonicum) infection or Carbon tetrachloride (CCl4) intraperiton...

Full description

Bibliographic Details
Main Authors: Li-Jun Song, Xu-Ren Yin, Sha-Sha Mu, Jia-Huang Li, Hong Gao, Ying Zhang, Pan-Pan Dong, Cong-Jin Mei, Zi-Chun Hua
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.570524/full
_version_ 1818316737783791616
author Li-Jun Song
Li-Jun Song
Li-Jun Song
Xu-Ren Yin
Sha-Sha Mu
Jia-Huang Li
Jia-Huang Li
Jia-Huang Li
Hong Gao
Ying Zhang
Pan-Pan Dong
Cong-Jin Mei
Zi-Chun Hua
Zi-Chun Hua
Zi-Chun Hua
author_facet Li-Jun Song
Li-Jun Song
Li-Jun Song
Xu-Ren Yin
Sha-Sha Mu
Jia-Huang Li
Jia-Huang Li
Jia-Huang Li
Hong Gao
Ying Zhang
Pan-Pan Dong
Cong-Jin Mei
Zi-Chun Hua
Zi-Chun Hua
Zi-Chun Hua
author_sort Li-Jun Song
collection DOAJ
description Liver fibrosis can result from various causes and could progress to cirrhosis and cancer; however, there are no effective treatments due to that its molecular mechanism is unclear. liver fibrosis model made by Schistosoma japonicum (S. japonicum) infection or Carbon tetrachloride (CCl4) intraperitoneal injection is a conventional model used in liver fibrosis-related studies for mechanism or pharmaceutical research purposes. But the differences in the pathological progression, immune responses and the underlying mechanism between the two liver fibrosis model have not been carefully compared and characterized, which hinders us from correctly understanding and making better use of the two models. In the present study, the pathological changes to the liver, and the cytokines, inflammatory factors, macrophages, and lymphocytes subsets involved were analyzed in the liver fibrosis model of S. japonicum infection or CCl4 intraperitoneal injection. Additionally, the pathological progression, immune responses and the underlying injury mechanism in these two models were compared and characterized. The results showed that the changing trend of interleukin-13 (IL-13), transforming growth factor beta (TGF-β), inflammatory factors, and M1, M2 macrophages, were consistent with the development trend of fibrosis regardless of whether liver fibrosis was caused by S. japonicum or CCl4. For lymphocyte subsets, the proportions of CD3+ T cells and CD4+ T cells decreased gradually, while proportion of CD8+ T cells peaked at 6 weeks in mice infected with S. japonicum and at 12 weeks in mice injected with CCl4. With prolonged S. japonicum infection time, Th1 (CD4+IFN-γ+) immunity converted to Th2 (CD4+IL-4+)/Th17 (CD4+IL-17+) with weaker regulatory T cell (Treg) (CD4+CD25+FOXP3+) immunity. However, in liver fibrosis caused by CCl4, Th1 cells occupied the dominant position, while proportions of Th2, Th17, and Treg cells decreased gradually. In conclusion, liver fibrosis was a complex pathological process that was regulated by a series of cytokines and immune cells. The pathological progressions and immune responses to S. japonicum or CCl4 induced liver fibrosis were different, possibly because of their different injury mechanisms. The appropriate animal model should be selected according to the needs of different experiments and the pathogenic factors of liver fibrosis in the study.
first_indexed 2024-12-13T09:26:11Z
format Article
id doaj.art-96d2c4da9b51445cb6c774a859797c1c
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-13T09:26:11Z
publishDate 2020-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-96d2c4da9b51445cb6c774a859797c1c2022-12-21T23:52:37ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-10-011110.3389/fimmu.2020.570524570524The Differential and Dynamic Progression of Hepatic Inflammation and Immune Responses During Liver Fibrosis Induced by Schistosoma japonicum or Carbon Tetrachloride in MiceLi-Jun Song0Li-Jun Song1Li-Jun Song2Xu-Ren Yin3Sha-Sha Mu4Jia-Huang Li5Jia-Huang Li6Jia-Huang Li7Hong Gao8Ying Zhang9Pan-Pan Dong10Cong-Jin Mei11Zi-Chun Hua12Zi-Chun Hua13Zi-Chun Hua14School of Life Sciences and the State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, ChinaNational Health Commission Key Laboratory of Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi, ChinaPublic Health Research Center, Jiangnan University, Wuxi, ChinaNational Health Commission Key Laboratory of Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi, ChinaNational Health Commission Key Laboratory of Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi, ChinaSchool of Life Sciences and the State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, ChinaSchool of Biopharmacy, China Pharmaceutical University, Nanjing, ChinaJiangsu TargetPharma Laboratories Inc., Changzhou High-Tech Research Institute of Nanjing University, Changzhou, ChinaDepartment of Pathology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, ChinaNational Health Commission Key Laboratory of Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi, ChinaNational Health Commission Key Laboratory of Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi, ChinaNational Health Commission Key Laboratory of Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi, ChinaSchool of Life Sciences and the State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, ChinaSchool of Biopharmacy, China Pharmaceutical University, Nanjing, ChinaJiangsu TargetPharma Laboratories Inc., Changzhou High-Tech Research Institute of Nanjing University, Changzhou, ChinaLiver fibrosis can result from various causes and could progress to cirrhosis and cancer; however, there are no effective treatments due to that its molecular mechanism is unclear. liver fibrosis model made by Schistosoma japonicum (S. japonicum) infection or Carbon tetrachloride (CCl4) intraperitoneal injection is a conventional model used in liver fibrosis-related studies for mechanism or pharmaceutical research purposes. But the differences in the pathological progression, immune responses and the underlying mechanism between the two liver fibrosis model have not been carefully compared and characterized, which hinders us from correctly understanding and making better use of the two models. In the present study, the pathological changes to the liver, and the cytokines, inflammatory factors, macrophages, and lymphocytes subsets involved were analyzed in the liver fibrosis model of S. japonicum infection or CCl4 intraperitoneal injection. Additionally, the pathological progression, immune responses and the underlying injury mechanism in these two models were compared and characterized. The results showed that the changing trend of interleukin-13 (IL-13), transforming growth factor beta (TGF-β), inflammatory factors, and M1, M2 macrophages, were consistent with the development trend of fibrosis regardless of whether liver fibrosis was caused by S. japonicum or CCl4. For lymphocyte subsets, the proportions of CD3+ T cells and CD4+ T cells decreased gradually, while proportion of CD8+ T cells peaked at 6 weeks in mice infected with S. japonicum and at 12 weeks in mice injected with CCl4. With prolonged S. japonicum infection time, Th1 (CD4+IFN-γ+) immunity converted to Th2 (CD4+IL-4+)/Th17 (CD4+IL-17+) with weaker regulatory T cell (Treg) (CD4+CD25+FOXP3+) immunity. However, in liver fibrosis caused by CCl4, Th1 cells occupied the dominant position, while proportions of Th2, Th17, and Treg cells decreased gradually. In conclusion, liver fibrosis was a complex pathological process that was regulated by a series of cytokines and immune cells. The pathological progressions and immune responses to S. japonicum or CCl4 induced liver fibrosis were different, possibly because of their different injury mechanisms. The appropriate animal model should be selected according to the needs of different experiments and the pathogenic factors of liver fibrosis in the study.https://www.frontiersin.org/article/10.3389/fimmu.2020.570524/fullliver fibrosisSchistosoma japonicumcarbon tetrachloridehepatic inflammationimmune responsedynamic progression
spellingShingle Li-Jun Song
Li-Jun Song
Li-Jun Song
Xu-Ren Yin
Sha-Sha Mu
Jia-Huang Li
Jia-Huang Li
Jia-Huang Li
Hong Gao
Ying Zhang
Pan-Pan Dong
Cong-Jin Mei
Zi-Chun Hua
Zi-Chun Hua
Zi-Chun Hua
The Differential and Dynamic Progression of Hepatic Inflammation and Immune Responses During Liver Fibrosis Induced by Schistosoma japonicum or Carbon Tetrachloride in Mice
Frontiers in Immunology
liver fibrosis
Schistosoma japonicum
carbon tetrachloride
hepatic inflammation
immune response
dynamic progression
title The Differential and Dynamic Progression of Hepatic Inflammation and Immune Responses During Liver Fibrosis Induced by Schistosoma japonicum or Carbon Tetrachloride in Mice
title_full The Differential and Dynamic Progression of Hepatic Inflammation and Immune Responses During Liver Fibrosis Induced by Schistosoma japonicum or Carbon Tetrachloride in Mice
title_fullStr The Differential and Dynamic Progression of Hepatic Inflammation and Immune Responses During Liver Fibrosis Induced by Schistosoma japonicum or Carbon Tetrachloride in Mice
title_full_unstemmed The Differential and Dynamic Progression of Hepatic Inflammation and Immune Responses During Liver Fibrosis Induced by Schistosoma japonicum or Carbon Tetrachloride in Mice
title_short The Differential and Dynamic Progression of Hepatic Inflammation and Immune Responses During Liver Fibrosis Induced by Schistosoma japonicum or Carbon Tetrachloride in Mice
title_sort differential and dynamic progression of hepatic inflammation and immune responses during liver fibrosis induced by schistosoma japonicum or carbon tetrachloride in mice
topic liver fibrosis
Schistosoma japonicum
carbon tetrachloride
hepatic inflammation
immune response
dynamic progression
url https://www.frontiersin.org/article/10.3389/fimmu.2020.570524/full
work_keys_str_mv AT lijunsong thedifferentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT lijunsong thedifferentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT lijunsong thedifferentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT xurenyin thedifferentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT shashamu thedifferentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT jiahuangli thedifferentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT jiahuangli thedifferentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT jiahuangli thedifferentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT honggao thedifferentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT yingzhang thedifferentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT panpandong thedifferentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT congjinmei thedifferentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT zichunhua thedifferentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT zichunhua thedifferentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT zichunhua thedifferentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT lijunsong differentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT lijunsong differentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT lijunsong differentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT xurenyin differentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT shashamu differentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT jiahuangli differentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT jiahuangli differentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT jiahuangli differentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT honggao differentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT yingzhang differentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT panpandong differentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT congjinmei differentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT zichunhua differentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT zichunhua differentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice
AT zichunhua differentialanddynamicprogressionofhepaticinflammationandimmuneresponsesduringliverfibrosisinducedbyschistosomajaponicumorcarbontetrachlorideinmice